<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<dataset>
    <author>Ruiz, María Esperanza</author>
    <author>Scioli Montoto, Sebastián</author>
    <author>Talevi, Alan</author>
    <fecha>2026</fecha>
    <handle>11336/285412</handle>
    <idioma>eng</idioma>
    <relationtype>http://ricifa.com.ar/</relationtype>
    <relationtype>https://www.medicinabuenosaires.com/indices-de-2020/</relationtype>
    <relationtype>http://dx.doi.org/10.3390/pharmaceutics18040503</relationtype>
    <rights>info:eu-repo/semantics/openAccess</rights>
    <rightsUri>https://creativecommons.org/licenses/by-nc-sa/2.5/ar/</rightsUri>
    <subject>Sistema de liberación de fármacos</subject>
    <subject>Nanopartículas</subject>
    <subject>Estiripentol</subject>
    <subject>Cannabidiol</subject>
    <subject>Síndrome de Dravet</subject>
    <subject>Farmacocinética</subject>
    <title>Statistical optimization, physicochemical characterization, in vitro release and pre-clinical PK of nanostructured lipid carriers loaded with stiripentol and cannabidiol</title>
    <type>dataset</type>
</dataset>
